Browse by Poster Presenter

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

N
Nabeshima, Akira

Kyushu University
(P 203) IMPACT OF COVID-19 PANDEMIC ON BONE AND SOFT TISSUE SARCOMA PATIENTS' CONSULTATION AND DIAGNOSIS
Akira Nabeshima
Favorite
Nacev, Benjamin

University of Pittsburgh Hillman Cancer Center
(P 229) EXPRESSION OF TRANSPOSABLE ELEMENTS AND IKZF1 PREDICTS IMMUNE INFILTRATES IN SARCOMAS AND CORRELATES WITH OUTCOMES AFTER IMMUNE CHECKPOINT INHIBITION
Benjamin Nacev
Favorite
(P 392) ATRX LOSS IN UTERINE LEIOMYOSARCOMA IS ASSOCIATED WITH WORSE OVERALL SURVIVAL AND A DISTINCT PATTERN OF GENE EXPRESSION ACROSS SUBTYPES
Benjamin Nacev
Favorite
Nadesan, Puvi

Duke University
(P 15) HISTONE DEACETYLASE-3 PLAYS A ROLE IN THE METASTATIC POTENTIAL OF A SUBPOPULATION OF CELLS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Puvi Nadesan
Favorite
Nafii, Yosef

USF Morsani College of Medicine
(P 263) HEMI- VS. REVERSE SHOULDER ARTHROPLASTY OUTCOMES FOLLOWING PROXIMAL HUMERAL ONCOLOGIC RESECTION
Yosef Nafii
Favorite
Nakahara, Ichiro

National Hospital Organization Osaka Minami Medical Center
(P 272) OUTCOMES OF FOUR CASES OF TOTAL HIP ARTHROPLASTY (THA) WITH POROUS TANTALUM IMPLANT AFTER PARTIAL ACETABULAR RESECTION USING 3D PREOPERATIVE PLANNING FOR PELVIC BONE TUMORS
Ichiro Nakahara
Favorite
Nakai, Sho

Osaka International Cancer Institute
(P 324) BENZIMIDAZOLE DERIVATIVES AS NOVEL THERAPEUTIC AGENTS FOR INI1-DEFICIENT EPITHELIOID SARCOMA
Sho Nakai
Favorite
Nakai, Sho

Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine
(P 387) SUCCESSFUL PAZOPANIB TREATMENT OF UNDIFFERENTIATED PLEOMORPHIC SARCOMA WITH COAMPLIFICATION OF PDGFRA, VEGFR2, AND KIT: A CASE REPORT
Sho Nakai
Favorite
Nakashima, Yasuharu

Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University
(P 203) IMPACT OF COVID-19 PANDEMIC ON BONE AND SOFT TISSUE SARCOMA PATIENTS' CONSULTATION AND DIAGNOSIS
Yasuharu Nakashima
Favorite
Nakayama, Robert

Department of Orthopaedic Surgery, Keio University School of Medicine
(P 220) SPORTS ACTIVITIES IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT SURVIVORS OF MALIGNANT BONE SARCOMAS
Robert Nakayama
Favorite
Nakazawa, Michael

MD Anderson Cancer Center
(P 110) INTERNATIONAL MULTICENTER RETROSPECTIVE STUDY OF PLEOMORPHIC RHABDOMYOSARCOMA (P-RMS), A PUSH PLATFORM STUDY: OUTCOME OF LOCALIZED AND ADVANCED DISEASE
Michael Nakazawa
Favorite
(P 111) INTERNATIONAL MULTICENTER RETROSPECTIVE STUDY OF SPINDLE CELL/ SCLEROSING RHABDOMYOSARCOMA (S-RMS), A PUSH PLATFORM STUDY: OUTCOME OF LOCALIZED AND ADVANCED DISEASE
Michael Nakazawa
Favorite
(P 233) IMMUNE CLASSES OF LEIOMYOSARCOMA DRIVEN BY B CELL INFILTRATE AND CTLA4 EXPRESSION
Michael Nakazawa
Favorite
Namciu, Stephanie

Seattle Children's Research Institute
(P 330) EFFICACY OF NON-CARDIOTOXIC ANTHRACYCLINES IN EWING SARCOMA
Stephanie Namciu
Favorite
Namer, Izzie-Jacques

iCube UMR 7357 - Laboratory for Engineering, Computer Science and Imaging- University Hospital of Strasbourg
(P 75) METABOLIC EVALUATION OF THE RELATIONSHIP BETWEEN MACROPHAGES AND OSTEOSARCOMA TUMOR CELLS
Izzie-Jacques Namer
Favorite
(P 89) TARGETED THERAPY OF MET, TYROSINE KINASE RECEPTOR, IN PEDIATRIC HIGH-GRADE OSTEOSARCOMAS : A NEW WAY TO TREAT PATIENTS ?
Izzie-Jacques Namer
Favorite
Napolitano, Andrea

The Royal Marsden NHS Foundation Trust
(P 183) A RETROSPECTIVE STUDY OF THE EFFECTS OF PATIENT, DISEASE, AND TREATMENT FACTORS ON SURVIVAL OUTCOMES IN PATIENTS WITH SOFT TISSUE SARCOMA BRAIN METASTASES
Andrea Napolitano
Favorite
Nara, Satoshi

Department of Hepatoibiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan
(P 134) REAL-WORLD CLINICAL OUTCOME OF NEOADJUVANT CHEMOTHERAPY FOR RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA
Satoshi Nara
Favorite
Narasimhan, Supraja

Deciphera Pharmaceuticals, A member of ONO Pharma
(P 43) SAFETY AND EFFICACY WITH VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR WHO RECEIVED NO PRIOR ANTI-COLONY-STIMULATING FACTOR 1 THERAPY: ONGOING PHASE 2 STUDY
Supraja Narasimhan
Favorite
Narayanaswamy, Prabha

Seattle Children's Research Institute
(P 226) EARLY EXPERIENCE ON ENLIGHTEN-01: A PHASE 1 STUDY OF BISPECIFIC ADAPTER MOLECULE- CONTROLLED FOLATE RECEPTOR CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY OSTEOSARCOMA
Prabha Narayanaswamy
Favorite
Narayan, Raja

Loma Linda University
(P 371) ELUCIDATING THE CLINICAL UTILITY OF TARGETED GENE EXPRESSION PROFILING IN RETROPERITONEAL LIPOSARCOMA
Raja Narayan
Favorite
Nardini, Claudia

Ospedale Pediatrico Bambino Gesù
(P 311) QUANTIFICATION OF TUMOUR-INFILTRATING IMMUNE CELLS THROUGH DECONVOLUTION OF DNA METHYLATION DATA IN EWING SARCOMAS
Claudia Nardini
Favorite
Nardi, Walter

Buenos Aires British Hospital
(P 25) PRIMARY TREATED VERSUS REFERRED TRUNK AND EXTREMITIES SOFT TISSUE SARCOMAS: ANALYSIS OF TREATMENT IMPACT IN A SPECIALIZED CENTER IN ARGENTINA.
Walter Nardi
Favorite
(P 366) ABDOMINAL AORTA RESECTION EN-BLOC WITH PRIMARY RETROPERITONEAL SOFT-TISSUE SARCOMA AND BI-ILIAC GRAFT RECONSTRUCTION.
Walter Nardi
Favorite
Narta, Kiran

University of Calgary
(P 236) INTERFERON STIMULATED GENE SCORES ARE ELEVATED IN THE MYELOID COMPARTMENT OF MURINE KP UNDIFFERENTIATED PLEOMORPHIC TUMORS TREATED WITH TRANSLATIONAL STING AGONISTS
Kiran Narta
Favorite
(P 327) CHARACTERIZATION OF TWO NOVEL IMMUNE COMPETENT, MURINE MODELS OF SOFT TISSUE SARCOMA
Kiran Narta
Favorite
(P 333) ESTIMATING IMMUNE INFILTRATES OF NOVEL GENETICALLY ENGINEERED MOUSE MODELS OF UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Kiran Narta
Favorite
(P 422) COMPARISON OF ANNOTATION METHODS FOR PAN-SARCOMA SINGLE CELL DATA
Kiran Narta
Favorite
Nash, Joshua

The Hospital for Sick Children
(P 159) USING THE TRANSCRIPTIONAL SPECTRUM OF UTERINE SMOOTH MUSCLE TUMORS TO IDENTIFY PROGNOSTIC SIGNATURES FOR ABNORMAL LEIOMYOMAS AND SMOOTH MUSCLE TUMOURS OF UNCERTAIN MALIGNANT POTENTIAL
Joshua Nash
Favorite
(P 329) DEVELOPING ARMS METASTATIC MODELS TO RECAPITULATE THE TUMOR MICROENVIRONMENTS OF THE AXILLA/LYMPH NODE AND LUNGS
Joshua Nash
Favorite
Nassif Haddad, Elise

The University of Texas MD Anderson Cancer Center
(P 130) HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RESECTABLE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA (DDLPS) TREATED WITH NEOADJUVANT CHECKPOINT BLOCKADE IN A RANDOMIZED PHASE II CLINICAL TRIAL.
Elise Nassif Haddad
Favorite
(P 233) IMMUNE CLASSES OF LEIOMYOSARCOMA DRIVEN BY B CELL INFILTRATE AND CTLA4 EXPRESSION
Elise Nassif Haddad
Favorite
(P 325) CAN PROTEOMICS PREDICT METASTATIC RELAPSE IN LEIOMYOSARCOMA? DEVELOPMENT OF AN 8 PROTEIN SIGNATURE IN A >350 SAMPLE STUDY INCLUDING A VALIDATION COHORT
Elise Nassif Haddad
Favorite
Natale, Jordan

Roswell Park Comprehensive Cancer Center
(P 35) EARLY REAL WORLD EXPERIENCE WITH NIROGACESTAT IN PATIENTS WITH DESMOID FIBROMATOSIS
Jordan Natale
Favorite
Nathrath, Michaela

Klinikum Kassel
(P 03) CDK4 IS CO-AMPLIFIED WITH EITHER TP53 PROMOTER GENE FUSIONS OR MDM2 THROUGH DISTINCT MECHANISMS IN OSTEOSARCOMA
Michaela Nathrath
Favorite
(P 26) SARCDBASE: A TOOL FOR DETECTION OF GENETIC ALTERATIONS IN SARCOMA
Michaela Nathrath
Favorite
Nations, Troy

Texas Tech University Health Sciences Center
(P 292) CHARACTERIZATION OF TELOMERE MAINTENANCE MECHANISMS IN OSTEOSARCOMA PATIENT-DERIVED LABORATORY MODELS
Troy Nations
Favorite
Navai, Shoba

Baylor College of Medicine
(P 417) VITAS: ATEZOLIZUMAB IN COMBINATION WITH CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY SOLID TUMORS: AN OPEN-LABEL, PHASE I/II, SINGLE-ARM, MULTI-CENTER TRIAL IN PROGRESS
Shoba Navai
Favorite
Navarria, Pierina

Humanitas Research Hospital
(P 155) PRIMARY MESENCHYMAL TUMORS OF THE HEART: A 8-YEARS, SINGLE INSTITUTION EXPERIENCE
Pierina Navarria
Favorite
(P 431) REAL-WORLD EXPERIENCE OF EFFICACY AND TOLERABILITY OF CONTINUOS INFUSION IFOSFAMIDE AMONG ADVANCED SOFT TISSUE AND BONE SARCOMAS PATIENTS: A SINGLE CENTRE RETROSPECTIVE COHORT.
Pierina Navarria
Favorite
Navid, Fariba

Children's Hospital Los Angeles
(P 76) MOLECULAR AND CHROMOSOMAL MICROARRAY PROFILING OF OSTEOSARCOMA IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS: A SINGLE INSTITUTION REPORT
Fariba Navid
Favorite
Nayak, Prakash

Tata Memorial Hospital
(P 32) CURRENT INDICATIONS OF OPEN SURGERY IN PRIMARY APPENDICULAR/ PELVIC ANEURYSMAL BONE CYSTS
Prakash Nayak
Favorite
(P 306) LONG TERM OUTCOMES OF TYPE BIIIA ROTATIONPLASTY AFTER TOTAL FEMUR EXCISION IN CHILDREN
Prakash Nayak
Favorite
Nazon, Charlotte

University Hospital of Strasbourg
(P 426) GD2 HETEROGENEIC EXPRESSION IN OSTEOSARCOMAS AND EWING SARCOMAS UNDERLYING A WORST PROGNOSIS
Charlotte Nazon
Favorite
Ndengu, Andoyo

Memorial Sloan Kettering Cancer Center
(P 338) PRECLINICAL EFFICACY OF DAN-222, A NOVEL POLYMERIC NANOPARTICLE, IN PEDIATRIC SOLID TUMOR MODELS
Andoyo Ndengu
Favorite
Neal, Jill

Clear Cell Sarcoma Foundation
(P 189) CLEAR CELL SARCOMA - REAL WORLD DATA ANALYSIS
Jill Neal
Favorite
Neefjes, Jacques

Leiden University Medical Center
(P 330) EFFICACY OF NON-CARDIOTOXIC ANTHRACYCLINES IN EWING SARCOMA
Jacques Neefjes
Favorite
Negrón-Lomas, Claudia

Research Institute McGill University Health Center
(P 69) H3.3G34W ONCOHISTONE IN OSTEOSARCOMA
Claudia Negrón-Lomas
Favorite
Neilson, Amber

Genome Engineering & Stem Cell Center (GESC@MGI) Dept. of Genetics, Washington University in St. Louis School of Medicine
(P 10) GENERATION OF A CHROMOSOME 8 GAIN;NF1-/- HUMAN INDUCED PLURIPOTENT STEM CELL DERIVED SCHWANN CELL PRECURSOR MODEL
Amber Neilson
Favorite
Nepal, Bal

Ontada
(P 133) REAL-WORLD ANALYSIS OF DEDIFFERENTIATED LIPOSARCOMA (DDLPS) IN A US COMMUNITY ONCOLOGY SETTING
Bal Nepal
Favorite
Nessim, Carolyn

Ottawa Hospital Research Institute
(P 378) INGUINAL SARCOMAS - A RETROSPECTIVE ANALYSIS OF DIAGNOSIS, CLINICAL FEATURES, TREATMENT PATTERNS AND OUTCOMES (I-SARC): A STUDY BY TARPSWG
Carolyn Nessim
Favorite
(P 390) VARIATIONS IN GLOBAL PATTERNS OF CARE FOR RETROPERITONEAL SARCOMAS - A STUDY BY TARPSWG
Carolyn Nessim
Favorite
Nester, Matthew

USF Health Morsani College of Medicine
(P 257) COMPARATIVE OUTCOMES OF CONSTRAINED ACETABULAR LINERS VS. DUAL MOBILITY CUPS IN COMPLEX HIP RECONSTURCTION FOR METASTATIC BONE DISEASE
Matthew Nester
Favorite
(P 262) EVALUATION OF STAGED RESECTION WITH TEMPORIZING VAC OF SOFT TISSUE SARCOMAS
Matthew Nester
Favorite
Nester, Matthew

University of South Florida Morsani College of Medicine
(P 279) SIGNIFICANCE OF TIP-APEX DISTANCE IN ACTUAL AND IMPENDING PATHOLOGICAL FRACTURES OF THE PROXIMAL FEMUR
Matthew Nester
Favorite
Neu, Natascha

Chrestos Concept GmbH & Co. KG, Essen, Germany
(P 393) EFFICACY AND SAFETY OF LAROTRECTINIB AS FIRST-LINE TREATMENT IN PATIENTS WITH TRK FUSION SARCOMAS
Natascha Neu
Favorite
(P 396) LONG-TERM FOLLOW-UP EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT PATIENTS WITH TRK FUSION SARCOMAS
Natascha Neu
Favorite
Nevens, Thomas

UZ Leuven
(P 291) CASE REPORT: RADICAL EN BLOC MULTI-LEVEL SPONDYLECTOMY FOR A LOCALLY RECURRENT OSTEOSARCOMA
Thomas Nevens
Favorite
Nezu, Yutaka

Kanagawa Cancer Center
(P 220) SPORTS ACTIVITIES IN PEDIATRIC, ADOLESCENT, AND YOUNG ADULT SURVIVORS OF MALIGNANT BONE SARCOMAS
Yutaka Nezu
Favorite
Ng, Deanna

University of Toronto
(P 376) IMPACT OF SITE OF ORIGIN ON THE PROGNOSIS OF PATIENTS WITH PRIMARY RESECTABLE NON-UTERINE ABDOMINAL LEIOMYOSARCOMA
Deanna Ng
Favorite
Ng, Juliana

Northwestern University, Feinberg School of Medicine
(P 222) ANALYSIS OF THE CITN-13 SARCOMA ARM: PEMBROLIZUMAB AND INTERFERON GAMMA FOR SYNOVIAL SARCOMA AND MYXOID/ ROUND CELL LIPOSARCOMA
Juliana Ng
Favorite
(P 235) INFILTRATION OF MUCOSAL-ASSOCIATED INVARIANT T CELLS (MAITS) INTO CHONDROSARCOMA TUMORS
Juliana Ng
Favorite
Nguyen, Gia Hoang Nam

Oslo University Hospital
(P 40) PEGYLATED LIPOSOMAL DOXORUBICIN IN SYMPTOMATIC DESMOID TUMOR
Gia Hoang Nam Nguyen
Favorite
Nguyen, Sa

University of Texas MD Anderson Cancer Center
(P 130) HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH RESECTABLE RETROPERITONEAL DEDIFFERENTIATED LIPOSARCOMA (DDLPS) TREATED WITH NEOADJUVANT CHECKPOINT BLOCKADE IN A RANDOMIZED PHASE II CLINICAL TRIAL.
Sa Nguyen
Favorite
Nguyen, Sang

Vanderbilt University Medical Center
(P 199) FINANCIAL TOXICITY AMONG SARCOMA PATIENTS AND ASSOCIATED FACTORS
Sang Nguyen
Favorite
Nguyen, Trang

Washington University, St. Louis
(P 384) REAL WORLD EXPERIENCE IN TREATING HEPATIC EPITHELIOID HEMANGIOENDOTHELIOMA: AN ULTRA-RARE VASCULAR TUMOR
Trang Nguyen
Favorite
Nicholls, Lauren

Baylor College of Medicine
(P 315) SALVAGE THERAPY EFFICACY IS MODIFIED BY RISK GROUP AT DIAGNOSIS IN PATIENTS WITH RELAPSED RHABDOMYOSARCOMA
Lauren Nicholls
Favorite
Nicoli, Fabio

Northumbria Healthcare NHS Foundation Trust
(P 269) LYMPHOEDEMA FOLLOWING LIMB SALVAGE SURGERY FOR EXTREMITY SARCOMA: A RETROSPECTIVE ANALYSIS OF 282 PATIENTS
Fabio Nicoli
Favorite
Nielsen, Morten

National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital
(P 243) MYELOSUPPRESSION FOLLOWING LYMPHODEPLETING CHEMOTHERAPY AS PART OF ADOPTIVE CELL THERAPY FOR PATIENTS WITH PROGRESSIVE SOFT TISSUE SARCOMA AFTER STANDARD CHEMOTHERAPY
Morten Nielsen
Favorite
Nielsen, Petur
(P 63) DOES TUMOR NECROSIS IMPACT PROGNOSIS IN CHONDROBLASTIC AND OSTEOBLASTIC OSTEOSARCOMA? A STUDY FROM A LARGE TERTIARY CARE ACADEMIC CENTER
Petur Nielsen
Favorite
Nielsen, Torsten

University of British Columbia
(P 343) TLE1 DISRUPTION DOES NOT IMPEDE SYNOVIAL SARCOMAGENESIS
Torsten Nielsen
Favorite
Niewel, Manuela

Peptomyc, S.L.
(P 408) OSTEOMYC: A PHASE 2 PILOT STUDY TO EVALIATE THE SAFETY AND THE ANTITUMOR ACTIVITY OF THE MYC INHIBITOR OMO-103 ADMINISTERED INTRAVENOUSLY IN PATIENTS WITH ADVANCED HIGH GRADE OSTEOSARCOMA
Manuela Niewel
Favorite
Nilsson, Jenny

Lund University
(P 03) CDK4 IS CO-AMPLIFIED WITH EITHER TP53 PROMOTER GENE FUSIONS OR MDM2 THROUGH DISTINCT MECHANISMS IN OSTEOSARCOMA
Jenny Nilsson
Favorite
Nirgudkar, Neel

University of Miami Miller School of Medicine
(P 369) BLAND EMBOLIZATION AS ADJUNCT TREATMENT FOR HEPATIC EPITHELIOID HEMANGIOENDOTHELIOMA
Neel Nirgudkar
Favorite
Nishida, Yoshihiro

Nagoya university hospital
(P 280) SURGICAL OUTCOMES OF PELVIC CHONDROSARCOMA WITH A FOCUS ON WALKING ABILITY
Yoshihiro Nishida
Favorite
Nishisho, Toshihiko

Department of Orthopedics, Institute of Biomedical Sciences, Tokushima University Graduate School
(P 138) ACCURACY AND COMPLICATIONS OF CORE NEEDLE BIOPSY OF PERIPHERAL NERVE TUMORS
Toshihiko Nishisho
Favorite
Nitzan - Luques, Adi

SickKids hospital
(P 304) LOCAL CONTROL FOR PEDIATRIC RHABDOMYOSARCOMA OF THE EXTREMITIES. IS RADIOTHERAPY ALWAYS REQUIRED AFTER ADEQUATE SURGICAL RESECTION?
Adi Nitzan - Luques
Favorite
Niu, Ningning

The First Hospital of Jilin University
(P 119) UPDATED RESULTS OF A SINGLE-ARM,MULTI-CENTER STUDY OF ANLOTINIB COMBINED WITH TORIPALIMAB IN FIRST-LINE TREATMENT OF UNRESECTABLE OR METASTATIC UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Ningning Niu
Favorite
Niu, Xiaohui

Beijing Jishuitan Hospital, Capital Medical University
(P 407) LONG-TERM EFFICACY AND SAFETY PROFILE OF PIMICOTINIB (ABSK021) IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): PHASE 1B UPDATE.
Xiaohui Niu
Favorite
Niu, Xiao-Hui

Beijing Jishuitan Hospital, Capital Medical University, Beijing, China
(P 132) PATIENT CHARACTERISTICS, TREATMENT PATTERNS AND DISEASE BURDEN OF DEDIFFERENTIATED LIPOSARCOMA IN CHINA: A REAL-WORLD STUDY BASED ON NATIONAL CANCER REGISTRY
Xiao-Hui Niu
Favorite
Nizri, Eran

Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine
(P 378) INGUINAL SARCOMAS - A RETROSPECTIVE ANALYSIS OF DIAGNOSIS, CLINICAL FEATURES, TREATMENT PATTERNS AND OUTCOMES (I-SARC): A STUDY BY TARPSWG
Eran Nizri
Favorite
Nizri, Eran

Tel-Aviv Sourasky Medical Center
(P 390) VARIATIONS IN GLOBAL PATTERNS OF CARE FOR RETROPERITONEAL SARCOMAS - A STUDY BY TARPSWG
Eran Nizri
Favorite
Nordan, Taylor

Brigham and Women's Hospital
(P 167) DEFINING TEXTBOOK OUTCOMES FOR MINIMALLY INVASIVE SURGICAL RESECTION OF SMALL GASTROINTESTINAL STROMAL TUMORS (GIST) OF THE STOMACH
Taylor Nordan
Favorite
Norry, Elliot

Adaptimmune
(P 202) IMPACT OF AFAMI-CEL ON THE HEALTH STATE OF PATIENTS WITH ADVANCED SYNOVIAL SARCOMA OR MYXOID/ROUND CELL LIPOSARCOMA: COHORT 1 OF SPEARHEAD-1
Elliot Norry
Favorite
Noujaim, Jonathan

Hôpital Maisonneuve-Rosemont
(P 153) PATTERNS, MANAGEMENT AND SURVIVAL OUTCOMES OF PATIENTS WITH EPITHELIOID HEMANGIOENDOTHELIOMA: A NATIONWIDE ANALYSIS FROM THE CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION DATABASE
Jonathan Noujaim
Favorite
(P 212) REFERENCE SYSTEM OPTIMIZATION, ANALYSES OF THE IMPLEMENTATION OF A PROVINCIAL MULTIDISCIPLINARY SARCOMA NETWORK
Jonathan Noujaim
Favorite
(P 293) CIC-REARRANGED SOFT TISSUE SARCOMAS: DOES CHEMOTHERAPY CHANGE NATURAL HISTORY AND PROGNOSIS? A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) STUDY
Jonathan Noujaim
Favorite
(P 320) WHAT IS THE ROLE OF CHEMOTHERAPY IN PATIENTS (PTS) WITH SPINDLE CELL/SCLEROSING RHABDOMYOSARCOMA (SCRMS): A CANADIAN SARCOMA RESEARCH AND CLINICAL COLLABORATION (CANSARCC) STUDY
Jonathan Noujaim
Favorite
(P 394) IDENTIFYING THE INTERACTOME OF THE ONCOGENIC FUSIONS OF SARCOMAS TO REVEAL NOVEL THERAPEUTIC TARGETS
Jonathan Noujaim
Favorite
Novak, Marko

Institute of Oncology Ljubljana
(P 378) INGUINAL SARCOMAS - A RETROSPECTIVE ANALYSIS OF DIAGNOSIS, CLINICAL FEATURES, TREATMENT PATTERNS AND OUTCOMES (I-SARC): A STUDY BY TARPSWG
Marko Novak
Favorite
(P 390) VARIATIONS IN GLOBAL PATTERNS OF CARE FOR RETROPERITONEAL SARCOMAS - A STUDY BY TARPSWG
Marko Novak
Favorite
Nunez, Osvaldo

University of Miami Miller School of Medicine
(P 253) ASSESSING THE LINK BETWEEN MYXOFIBROSARCOMA RECURRENCE AND TREATMENT ORDER: A MULTIDISCIPLINARY RETROSPECTIVE COHORT STUDY
Osvaldo Nunez
Favorite
Nuss, Kalie

University of South Florida Morsani College of Medicine
(P 263) HEMI- VS. REVERSE SHOULDER ARTHROPLASTY OUTCOMES FOLLOWING PROXIMAL HUMERAL ONCOLOGIC RESECTION
Kalie Nuss
Favorite
Nyeng, Tine

Department of Oncology Medical Physics, Aarhus University Hospital
(P 357) RADIATION THERAPY OF EXTREMITY SOFT TISSUE SARCOMAS: A NATIONWIDE COHORT STUDY OF LATE SIDE EFFECTS - TRIAL IN PROGRESS
Tine Nyeng
Favorite
Nystrom, Lukas

Cleveland Clinic
(P 150) MODERN BIOPSY PRACTICE PATTERNS: A SURVEY OF THE MSTS MEMBERSHIP
Lukas Nystrom
Favorite